Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

LATEST
Chinese Genomics Company BGI to Provide Ethiopia with Coronavirus Testing Kits Made at African Plant
Trending in China: Autumn Milk Tea – Cynical Marketing Strategy or True Friendship?
IFC Mulls $80m Loan to Chinese Pig Rearing Firm Guangxi Yangxiang
Short Video Firm Kuaishou Optimizes Its E-Commerce By Connecting Livestreamers With Quality Products
Segway Owner Set to Make History With Shanghai IPO
BMW’s Use of High-Density Batteries Raises Safety Concerns
ByteDance Applies for Chinese Tech Export License as TikTok Negotiations Continue
Trending in China: Macau Eases Travel Restrictions but Will Covid-19 Tests Kill People’s Travel Bug?
Alibaba Subsidiary Cainiao Pushes Into Malaysia With Cross-Border Delivery Service
Trending in China: School Throws Away Students’ Food Deliveries To Force Use of Canteen
Chinese Electric Carmaker Li Auto Teams Up With U.S. Chipmaker Nvidia
JD.com-Backed Recycling Operator Wanwu Xinsheng Nets Over $100m
HSBC Shares Fall to Lowest Since 2009 As Investors Fret About Financial Crimes Report
Huawei Cuts R&D Investment and Jobs in Australia Amid Tech War
Tencent’s Navigation App Plans to Add Taxi-Hailing Feature to Compete with Baidu Maps, Alibaba-Backed Amap
JD.com Healthcare Unit Plans Hong Kong IPO
Hong Kong-Headquartered Plant-Based Food Producer Green Monday Closes $70 Million Funding Round
China-focused IDG Capital in Market For New $550m Venture Fund
Students at a Xi’an University Scream Over Quarantine Conditions
Industrial Drone-Maker Jouav Navigates Tech Tensions With IPO Plans
German Drugmaker BI to Establish Digital Lab in Shanghai

By Ding Yi / Mar 31, 2020 01:09 PM / Business & Tech

German drugmaker Boehringer Ingelheim (BI) will open a digital laboratory in July in Shanghai as part of efforts to penetrate the Chinese market, where pharmaceutical companies are scrambling to leverage digital technologies to boost their health care services.

With an initial investment of 3 million euros ($3.3 million), the laboratory, officially known as BI X, will look to recruit 20 experts in the field of digital health care to help develop medical products and therapies for the Chinese market, according to a statement published Monday on BI’s public WeChat account.

BI originally built the BI X laboratory at its headquarters in Germany in 2017, setting it up as an independent unit to the rest of the company. The lab works with specialists in the areas of data science, agile software development and user experience design to develop prototypes for new healthcare products and then turn them into applicable digital solutions.

The Shanghai-based facility is BI X’s first overseas branch outside Germany, the company said.

In recent years, foreign drugmakers have sought partnerships with China’s tech giants in a bid to ride the wave of the ongoing health care digital revolution.

Last year, Merck — BI’s German rival — and tech titan Tencent signed an agreement, under which Merck would use the Chinese company’s internet and artificial intelligence (AI) technologies to build a digital platform to improve public disease awareness and provide health care services to patients based in China.

In China, 94% of health care professionals use digital health technology or mobile health apps, while 39% of the general public in China thinks AI technology in health care aids more accurate diagnoses, according to a report by health technology firm Royal Philips published in 2019.

Contact reporter Ding Yi (yiding@caixin.com)

Related: Genome Giant BGI Gets Regulator Approval to Sell Coronavirus Test Kits


Share this article
Open WeChat and scan the QR code